EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?

John R Prensner, Jennifer G Abelin, Leron W Kok, Karl R Clauser, Jonathan M Mudge, Jorge Ruiz-Orera, Michal Bassani-Sternberg, Robert L Moritz, Eric W Deutsch, Sebastiaan van Heesch

Molecular & Cellular Proteomics · 2023-09 · 22 (9) · 100631

DOI: 10.1016/j.mcpro.2023.100631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2023-09. Verfasst von John R Prensner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of B…. Hauptthemen laut MEDLINE: Proteome, Protein Biosynthesis. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIA NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribosome profiling (Ribo-Seq) has proven transformative for our understanding of the human genome and proteome by illuminating thousands of noncanonical sites of ribosome translation outside the currently annotated coding sequences (CDSs). A conservative estimate suggests that at least 7000 noncanonical ORFs are translated, which, at first glance, has the potential to expand the number of human protein CDSs by 30%, from ∼19,500 annotated CDSs to over 26,000 annotated CDSs. Yet, additional scrutiny of these ORFs has raised numerous questions about what fraction of them truly produce a protein product and what fraction of those can be understood as proteins according to conventional understanding of the term. Adding further complication is the fact that published estimates of noncanonical ORFs vary widely by around 30-fold, from several thousand to several hundred thousand. The summation of this research has left the genomics and proteomics communities both excited by the prospect of new coding regions in the human genome but searching for guidance on how to proceed. Here, we discuss the current state of noncanonical ORF research, databases, and interpretation, focusing on how to assess whether a given ORF can be said to be "protein coding."

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomeProtein BiosynthesisHumansProteomicsRibosome ProfilingRibosomesOpen Reading Frames

Stichwörter der Autor:innen

Ribo-Seqimmunopeptidomicsmass spectrometrymicroproteinnoncanonical ORF

Substanzen

Proteome

Autor:innen und Institutionen

  • Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA; Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor,…
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK.
  • Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Ludwig Institute for Cancer Research, Agora Center Bugnon 25A, University of Lausanne, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; Agora Cancer…

Förderung

  • Wellcome Trust
  • NIA NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • NHGRI NIH HHS
  • National Human Genome Research Institute
  • National Institutes of Health
  • Stichting Villa Joep

Zitieren

APA

Prensner, J. R., Abelin, J. G., Kok, L. W., Clauser, K. R., Mudge, J. M., Ruiz-Orera, J., Bassani-Sternberg, M., Moritz, R. L., Deutsch, E. W., & van Heesch, S. (2023). What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?. Molecular & Cellular Proteomics, 22(9), 100631. https://doi.org/10.1016/j.mcpro.2023.100631

Vancouver

Prensner JR, Abelin JG, Kok LW, Clauser KR, Mudge JM, Ruiz-Orera J, et al. What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?. Molecular & Cellular Proteomics. 2023;22(9):100631. doi:10.1016/j.mcpro.2023.100631

BibTeX
@article{Prensner2023,
  author = {Prensner, John R and Abelin, Jennifer G and Kok, Leron W and Clauser, Karl R and Mudge, Jonathan M and Ruiz-Orera, Jorge and Bassani-Sternberg, Michal and Moritz, Robert L and Deutsch, Eric W and van Heesch, Sebastiaan},
  title = {What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?},
  journal = {Molecular & Cellular Proteomics},
  year = {2023},
  volume = {22},
  number = {9},
  pages = {100631},
  doi = {10.1016/j.mcpro.2023.100631}
}
Kostenlos starten →